A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
about
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in micePertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussisLive attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough.Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of miceSynergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge modelCross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelRole of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis.Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.Seroprevalence of pertussis in China: need to improve vaccination strategies.Relationship of immunogenicity to protective potency in acellular pertussis vaccines.Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age.gammadelta T cells regulate the early inflammatory response to bordetella pertussis infection in the murine respiratory tract.Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infectionImmune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model.Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens.T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.Characterization of co-purified acellular pertussis vaccines.Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.
P2860
Q24522458-45DB2356-7C80-446B-B8DA-2563758C9C0CQ24648031-56A1DC37-78AB-4D02-90FB-E42AF2E7B173Q24670399-CF462014-7DB7-4CCC-8F06-54BF29EAB67BQ30819553-B90BBD5D-FA6F-4B59-A107-48CE4B1C2E69Q30825645-F9F6DFDE-4AD9-45EE-930E-A6CE016DCBE9Q33553221-897DAEC8-DA06-4A84-9E04-802A3FC08B10Q33564283-ACDD588D-729A-490D-8193-C87DF8D8FB68Q33716587-6A99D3E8-75D5-4A2A-9DAF-F3F6FBCEBE41Q33796054-6BF427A1-E487-432C-BF57-7F59650509CFQ33825728-17DAEBED-140E-460C-BFAC-586AFAF2ADF2Q33825964-B3822736-88DC-434E-BB9D-8CDA8D83C378Q33866775-2DAAB9C7-1DE1-4E2F-A683-0118EFFF4F94Q34000504-74123851-91B6-42A1-9157-F404A81BBF49Q34002181-EF960984-343B-4088-B648-FA3772588B55Q34002672-A0EB0BC1-9074-4E04-9125-DA1D60435432Q34003483-A54110A8-5C82-44DA-A9A7-6DC4DAE897B7Q34003563-3D5DE394-BFDA-4DF0-BD8C-AF833129091BQ34008022-78F576D1-6CD5-4831-BAC7-9126EFFCFEA5Q34008317-2D921CFF-2F70-49F7-9D63-DD7B186E6216Q34066406-06A80EF9-BEFB-4E1D-A59D-16A8B41C3A6FQ34126969-DE2AD23A-D570-4BB3-9E09-B44D1E52D820Q34129001-0D3F15E4-A22B-4CBF-A2AA-D18C8EDD6BD2Q34271536-9A89BDF9-F206-4094-BCDC-88275049422BQ34291117-8946A674-0872-4412-903B-6FCA54918A1DQ34364307-7A20D0CD-3E4F-4565-9D49-E872CEB0A204Q34491729-6668B80B-F358-4AA4-98ED-8DE24E0E98F4Q34581910-FB0D4870-10A9-433D-8E30-6C6EA3370B24Q34593062-25B4D75E-DB50-42F9-8C94-865BEA02F887Q34601854-597A62C4-2242-4DF1-8A35-CF408BB9E34EQ34671882-8DBB2B20-CD2C-4703-8E46-2ABE48123582Q34738678-ABFDB09D-9569-4758-9A0F-AADF6407F641Q35035631-211DEE9B-CB8A-47E3-AF84-62B6372F5A68Q35066267-0F8EB95A-402E-4B6F-A912-1721CE742FDFQ35140321-2245B61A-E312-40C1-AE4B-20B9EB788E54Q35220336-441FFA15-408F-4CB2-BF15-453E35F02FF6Q35690023-EC87DDAD-D032-4688-BB3A-EDBDF6B83F87Q35887534-03E99CE1-C3D5-4022-A94B-929537CB37F7Q35946895-81C6E08E-BE65-4CA9-851B-69FF75ACBE17Q36109040-0D34E717-DD40-40FE-AEEA-B9741CF1E96EQ36313444-A3A7B89C-9729-4353-9D93-AB1AEFF9F426
P2860
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A murine model in which protec ...... against Bordetella pertussis.
@ast
A murine model in which protec ...... against Bordetella pertussis.
@en
type
label
A murine model in which protec ...... against Bordetella pertussis.
@ast
A murine model in which protec ...... against Bordetella pertussis.
@en
prefLabel
A murine model in which protec ...... against Bordetella pertussis.
@ast
A murine model in which protec ...... against Bordetella pertussis.
@en
P2093
P2860
P1476
A murine model in which protec ...... n against Bordetella pertussis
@en
P2093
P2860
P304
P407
P577
1998-02-01T00:00:00Z